參考文獻/References:
[1] 何偉.如何把握股骨頭壞死患者的保髖治療時機[J].中國骨與關(guān)節(jié)雜志,2016,5(2):82-86.
[2] 何莉莎,宋攀,趙林華,等.態(tài)靶辨證——中醫(yī)從宏觀走向精準(zhǔn)的歷史選擇[J].遼寧中醫(yī)雜志,2020,47(1):1-4.
[3] 何曉銘,龐鳳祥,李子祺,等.基于“態(tài)靶結(jié)合”理論探討股骨頭壞死囊性變的辨治思路[J].遼寧中醫(yī)雜志,2022,49(2):44-47.
[4] 莊至坤,魏秋實,張穎,等.基于“態(tài)靶結(jié)合”理論探討圍塌陷期股骨頭壞死精準(zhǔn)保髖[J].中華中醫(yī)藥學(xué)刊,2022,40(11):42-45.
[5] 沈瑩姍.基于不同病因股骨頭壞死“血瘀證”的表型差異探討絡(luò)病理論的科學(xué)價值[D].廣州:廣州中醫(yī)藥大學(xué),2021.
[6] 何曉銘,魏秋實,何偉,等.非創(chuàng)傷性股骨頭壞死患者的中醫(yī)證候及疼痛特點[J].中華中醫(yī)藥雜志,2020,35(7):3656-3659.
[7] 何曉銘,沈瑩姍,龐鳳祥,等.股骨頭壞死患者血瘀證診斷指標(biāo)的臨床調(diào)查研究[J].中華中醫(yī)藥雜志,2022,37(1):328-332.
[8] 魏秋實,何偉,張慶文,等.嶺南袁氏中醫(yī)藥防治股骨頭壞死傳承文化研究[J].新中醫(yī),2022,54(23):216-220.
[9] 沈瑩姍,烏日莎娜,莊至坤,等.基于病理表型辨析激素性與酒精性股骨頭壞死的血瘀證特點[J].中華中醫(yī)藥雜志,2021,36(8):4868-4872.
[10] 魏秋實,沈瑩姍,莊至坤,等.股骨頭壞死絡(luò)病理論的建立及科學(xué)價值[J].中華中醫(yī)藥學(xué)刊,2021,39(7):1-4.
[11] 烏日莎娜,沈瑩姍,袁穎嘉,等.基于“瘀去、新生、骨合”理論從細(xì)胞層面探討祛瘀、活血及補腎中藥治療股骨頭壞死的作用機制[J].中醫(yī)正骨,2022,34(4):61-63.
[12] 烏日莎娜,陳嘵俊,沈瑩姍,等.活血通絡(luò)膠囊通過OPG/RANKL/PDGF-BB通路對激素性股骨頭壞死模型大鼠的干預(yù)作用[J].中藥新藥與臨床藥理,2022,33(4):433-440.
[13] 韋雨柔,田佳慶,肖方駿,等.活血通絡(luò)膠囊對激素性股骨頭壞死大鼠腸道菌群影響的研究[J].中國全科醫(yī)學(xué),2023,26(29):3674-3682.
[14] 何憲順,韋雨柔,何敏聰,等.活血通絡(luò)法對激素性股骨頭壞死囊性變患者血清骨吸收/成血管/成骨蛋白調(diào)節(jié)作用的研究[J].中國全科醫(yī)學(xué),2024,27(12):1504-1510.
[15] HE M C,ZHANG J,CHEN X J,et al.Osteoclastic activity was associated with the development of steroid-induced osteonecrosis of femoral head[J].Artif Cells Nanomed Biotechnol,2020,48(1):1036-1046.
[16] WEI Q S,HONG G J,YUAN Y J,et al.Huo Xue Tong Luo capsule,a vasoactive herbal formula prevents progression of asymptomatic osteonecrosis of femoral head:a prospective study[J].J Orthop Translat,2019,18:65-73.
[17] HE X M,HE M C,YANG P,et al.The therapeutic effect of Huo Xue Tong Luo capsules in Association Research Circulation Osseous(ARCO)stageⅡ osteonecrosis of the femoral head:a clinical study with an average follow-up period of 7.95 years[J].Front Pharmacol,2021,12:773758.
[18] 魏秋實,何偉,張慶文,等.圍塌陷期股骨頭壞死不同影像學(xué)表現(xiàn)研究[J].中國修復(fù)重建外科雜志,2021,35(9):1105-1110.
[19] GLIMCHER M J,KENZORA J E.The biology of osteonecrosis of the human femoral head and its clinical implications:an abridged communication[J].Clin Orthop Relat Res,1978(130):47-50.
[20] ITO H,MATSUNO T,KANEDA K.Prognosis of early stage avascular necrosis of the femoral head[J].Clin Orthop Relat Res,1999(358):149-157.
[21] 魏秋實,楊帆,陳嘵俊,等.激素性與酒精性股骨頭壞死患者骨標(biāo)本壞死區(qū)域病理與顯微結(jié)構(gòu)特點分析[J].中國修復(fù)重建外科雜志,2018,32(7):866-872.
[22] 沈瑩姍,何敏聰,莊至坤,等.激素性股骨頭壞死和酒精性股骨頭壞死的病理學(xué)差異及其分子機制研究[J].中醫(yī)正骨,2023,35(5):1-7.
[23] 彭鵬,肖歡,方偉華,等.激素性股骨頭壞死囊性變組織骨修復(fù)機制分析與活血通絡(luò)膠囊含藥血清對肥大軟骨細(xì)胞成骨分化影響的實驗研究[J].中醫(yī)正骨,2024,36(9):19-28.
[24] 楊曉強,肖歡,田佳慶,等.活血通絡(luò)膠囊對激素性股骨頭壞死囊性變成血管修復(fù)的影響[J].中醫(yī)正骨,2024,36(9):40-48.
相似文獻/References:
[1]陳雷雷,張穎.何偉教授采用中醫(yī)藥療法治療股骨頭壞死的經(jīng)驗[J].中醫(yī)正骨,2015,27(10):74.
[2]徐西林,趙永蘭,張曉峰,等.活骨注射液髖關(guān)節(jié)腔灌注對兔股骨頭壞死模型
血管內(nèi)皮生長因子表達(dá)的動態(tài)影響[J].中醫(yī)正骨,2015,27(08):1.
XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):1.
[3]周勇,任菲菲,豐凡翔,等.血管內(nèi)皮生長因子和骨形態(tài)發(fā)生蛋白2
在非創(chuàng)傷性股骨頭壞死不同區(qū)域的表達(dá)[J].中醫(yī)正骨,2015,27(08):7.
ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):7.
[4]鮑榮華,王國平,夏曉斌,等.鉭棒植入治療非創(chuàng)傷性股骨頭壞死的療效觀察[J].中醫(yī)正骨,2015,27(02):28.
[5]張兵,馬凰富,劉波,等.非創(chuàng)傷性股骨頭壞死的舌象定量研究[J].中醫(yī)正骨,2015,27(04):8.
ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):8.
[6]李剛,程春生.股骨頭壞死血瘀證癥狀與平樂郭氏正骨方藥藥物組成
最大頻繁關(guān)聯(lián)模式挖掘[J].中醫(yī)正骨,2015,27(04):21.
LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):21.
[7]李文龍,梅沉成,杜貴強,等.微創(chuàng)減壓植骨多孔鉭棒植入治療
ARCOⅡ期非創(chuàng)傷性缺血性股骨頭壞死[J].中醫(yī)正骨,2016,28(02):43.
[8]張磊,金紅婷,童培建.骨健口服液早期干預(yù)非創(chuàng)傷性股骨頭壞死的臨床研究[J].中醫(yī)正骨,2016,28(03):14.
ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(09):14.
[9]鮑榮華,王國平,夏曉斌,等.直接前入路微創(chuàng)全髖關(guān)節(jié)置換術(shù)治療晚期股骨頭壞死[J].中醫(yī)正骨,2016,28(03):61.
[10]張超,姚晨,沈計榮.微創(chuàng)髓芯減壓打壓支撐植骨術(shù)結(jié)合補腎活血湯口服治療ARCOⅡ、Ⅲ期股骨頭壞死的近期療效觀察[J].中醫(yī)正骨,2016,28(03):20.
ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(09):20.